13 / 100

The Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) have launched a call for AMRIT (Anti-Microbial Resistance and Infection Treatment) Team Grants to support innovative research in combating antimicrobial resistance (AMR) and developing advanced infection treatments. This grant program encourages interdisciplinary teams of researchers, clinicians, and industry experts to collaborate on groundbreaking therapies, diagnostics, and vaccines to address AMR on a global scale.


Key Details of the AMRIT Team Grants

The AMRIT Team Grants provide substantial funding and resources for high-potential projects that offer practical and scalable solutions in AMR and infectious disease research.

  • Funding Scope: Full-cycle funding, covering discovery research through to early clinical validation.
  • Project Duration: Projects should be planned for 3-5 years, aligning with clinical development timelines.
  • Deadline for Submission: December 15, 2024. Applications submitted after this date may not be considered, so early preparation is recommended.
  • Grant Focus: Development of new antibiotics, vaccines, rapid diagnostics, and alternative therapies that tackle AMR effectively.
  • Collaborative Focus: Encouraging multi-institutional and interdisciplinary collaboration, particularly those involving academia, clinical practitioners, and industry partnerships.

Eligibility Criteria

The AMRIT Team Grants are open to a wide range of applicants within the Indian research and biotech ecosystem, including:

  • Academic and Research Institutions: Public research labs, universities, and government-affiliated institutes involved in life sciences and medical research.
  • Indian Industry Partners: Biotech and healthcare companies actively engaged in R&D for infectious diseases.
  • Collaborative Consortia: Multi-institutional collaborations are encouraged, fostering cross-disciplinary work between scientific researchers, clinicians, and industry partners.

Ideal applicants will have a promising prototype or validated research data that can advance to the next stage with additional funding and collaborative input.


Focus Areas for the AMRIT Program

The program seeks high-impact projects in key areas of infectious disease control and AMR, particularly those with applications in the Indian and global healthcare landscapes:

  • Novel Antibiotics and Antimicrobials: Targeting multi-resistant pathogens with new therapeutic approaches.
  • Vaccines and Immunotherapies: Development of preventive solutions to minimize infection rates and control AMR.
  • Diagnostics: Rapid, cost-effective diagnostic tools for real-time detection of infections and AMR status.
  • Alternative Therapies: Exploring non-traditional treatments like bacteriophage therapy, immunomodulation, and microbiome-based approaches.

These focus areas aim to provide sustainable, accessible, and impactful solutions to current challenges in infectious disease treatment and resistance management.


Application Process and Resources

  1. Download Application Documents: Prospective applicants should thoroughly review the guidelines, proforma, and advertisement documents. Key resources include:
  2. Prepare a Detailed Proposal: Applicants are encouraged to prepare a comprehensive proposal, including the project’s objectives, methodology, impact assessment, and detailed budget.
  3. Submit Online via BIRAC Portal: Registration and proposal submission can be completed through the BIRAC website. The application deadline is December 15, 2024.
  4. Evaluation and Selection: Submitted proposals will undergo a rigorous review process, assessed on their scientific merit, feasibility, and potential for commercialization.

Benefits of Participating in the AMRIT Team Grants Program

The AMRIT Team Grants offer a unique opportunity for researchers, clinicians, and industry partners to collaborate and bring high-potential solutions to life. Through this program, BIRAC and DBT provide not only funding but also access to mentorship, network support, and a pathway to accelerate research from lab to market.

If you are passionate about infectious disease research and have a novel idea with the potential to combat AMR, the AMRIT Team Grants could be your springboard to real-world impact. Apply by December 15, 2024, and join the mission to revolutionize infectious disease treatment.

Share this:

Like this:

Like Loading...

Discover more from dailyfirst

Subscribe to get the latest posts sent to your email.

Discover more from dailyfirst

Subscribe now to keep reading and get access to the full archive.

Continue reading